Sökning: "prothrombin fragment 1 2"
Visar resultat 11 - 14 av 14 avhandlingar innehållade orden prothrombin fragment 1 2.
11. Inflammation and Coagulation Activity in Unstable Coronary Artery Disease and the Influences of Thrombin Inhibition
Sammanfattning : In patients with unstable coronary artery disease, this study evaluated the degree of inflammation and coagulation activity, relations to myocardial cell damage, prognosis, and influences of randomisation to 72 h infusion with three different doses of inogatran, a direct thrombin inhibitor (n=904), or unfractionated heparin (n=305). Anticoagulant treatment effects were evaluated with aPT time. LÄS MER
12. Studies of haemostasis in acute coronary syndromes and diabetes mellitus
Sammanfattning : The pathophysiology of acute coronary syndromes (ACS) includes atherosclerotic plaque rupture and coronary thrombus formation. Antithrombotic treatment is effective but recurrent atherothrombotic or bleeding complications are not uncommon. LÄS MER
13. Effects of combined oral contraceptives on hemostasis and biochemical risk indicators for venous thromboembolism and atherothrombosis
Sammanfattning : Combined oral contraceptives (COCs) are one of the most common contraceptive methods in the world. Already a few years after their introduction, in the early 1960s, case reports were published showing associations between use of COCs and venous and arterial thromboembolism. LÄS MER
14. Haemostatic function in precocious myocardial infarction and vein graft occlusion after coronary artery bypass grafting
Sammanfattning : The present study examined the role of blood coagulation and fibrinolytic function in patients with coronary heart disease in two settings; in patients with precocious myocardial infarction in whom thrombosis is considered to constitute an important pathogenic mechanism and in unselected patients undergoing coronary artery bypass grafting (CABG) in whom early thrombotic occlusion of vein grafts is a considerable problem. Particular attention was paid to coagulation factor Vll and the tissue factor pathway inhibitor (TFPI) in the young post-infarction patients. LÄS MER